Axsome Therapeutics, Inc.
DE ˙ DB ˙ US05464T1043
199,30 € ↑9,50 (5,01%)
2026-06-04
AKTIENPREIS
SecurityDE:19X / Axsome Therapeutics, Inc.
InstitutionCaptrust Financial Advisors
Latest Disclosed Ownership11,566 shares
Latest Disclosed Value $ 1,954,792
Captrust Financial Advisors reports 2.86% increase in ownership of 19X / Axsome Therapeutics, Inc.

On May 14, 2026 - Captrust Financial Advisors filed a 13F-HR form disclosing ownership of 11,566 shares of Axsome Therapeutics, Inc. (DE:19X) valued at $1,622,710 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 11,244 shares of Axsome Therapeutics, Inc.. This represents a change in shares of 2.86% during the quarter. The current value of the position is $2,305,104 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F AXSOME THERAPEUTICS INC. COM Stock 05464T104 11,566 322 2.86 1,955 -4.82 0.0034
2026-02-17 2025-12-31 13F AXSOME THERAPEUTICS INC COM Stock 05464T104 11,244 3,285 41.27 2,054 112.53 0.0039
2025-11-19 2025-09-30 13F AXSOME THERAPEUTICS INC COM Stock 05464T104 7,959 967 13.83 967 32.51 0.0020
2025-08-15 2025-06-30 13F AXSOME THERAPEUTICS INC COM Stock 05464T104 6,992 3,888 125.26 730 101.38 0.0016
2025-05-15 2025-03-31 13F AXSOME THERAPEUTICS INC COM Stock 05464T104 3,104 151 5.11 362 45.38 0.0009
2025-02-14 2024-12-31 13F AXSOME THERAPEUTICS INC COM Stock 05464T104 2,953 -2,769 -48.39 250 -51.56 0.0007
2024-11-14 2024-09-30 13F AXSOME THERAPEUTICS INC COM Stock 05464T104 5,722 5,722 514 0.0015
2024-02-14 2023-12-31 13F AXSOME THERAPEUTICS INC COM Stock 05464T104 0 -2,881 -100.00 0 -100.00
2023-11-15 2023-09-30 13F AXSOME THERAPEUTICS INC COM Stock 05464T104 2,881 30 1.05 201 -1.47 0.0008
2023-08-15 2023-06-30 13F AXSOME THERAPEUTICS INC COM Stock 05464T104 2,851 2,851 205 0.0008
2022-11-16 2022-09-30 13F AXSOME THERAPEUTICS INC COM Common Stock 05464T104 0 -705 -100.00 0 -100.00
2022-08-23 2022-06-30 13F/A-1 AXSOME THERAPEUTICS INC COM Common Stock 05464T104 705 -52 -6.87 27 -12.90 0.0002
2022-08-16 2022-06-30 13F AXSOME THERAPEUTICS INC COM COM 05464T104 1,205 448 46 0.0003
2022-05-16 2022-03-31 13F AXSOME THERAPEUTICS COM 05464T104 757 646 581.98 31 675.00 0.0002
2022-02-14 2021-12-31 13F AXSOME THERAPEUTICS INC COM Common Stock 05464T104 111 35 46.05 4 33.33 0.0000
2021-11-16 2021-09-30 13F AXSOME THERAPEUTICS INC COM Common Stock 05464T104 76 16 26.67 3 -25.00 0.0000
2021-08-16 2021-06-30 13F AXSOME THERAPEUTICS INC COM Common Stock 05464T104 60 0 0.00 4 33.33 0.0000
2021-05-17 2021-03-31 13F AXSOME THERAPEUTICS INC COM Common Stock 05464T104 60 0 0.00 3 -40.00 0.0000
2021-02-16 2020-12-31 13F AXSOME THERAPEUTICS INC COM Common Stock 05464T104 60 0 0.00 5 25.00 0.0001
2020-11-17 2020-09-30 13F AXSOME THERAPEUTICS INC COM Common Stock 05464T104 60 60 4 0.0001
2020-08-14 2020-06-30 13F AXSOME THERAPEUTICS INC COM Common Stock 05464T104 0 -3,400 -100.00 0 -100.00
2020-05-15 2020-03-31 13F AXSOME THERAPEUTICS INC COM Common Stock 05464T104 3,400 -250 -6.85 190 -48.65 0.0042
2020-02-14 2019-12-31 13F AXSOME THERAPEUTICS COM 05464T104 3,650 3,650 370 0.0058
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.